All pages

From Wikilite

All pages Display pages starting at: Display pages ending at: Namespace: (Main) Talk User User talk Wikilite Wikilite talk File File talk MediaWiki MediaWiki talk Template Template talk Help Help talk Category Category talk

All pages | Previous page (07-2011Quality assurance for serum free light chain analysis)

---

07-2011Quality assurance for serum free light chain analysis	1 Introduction	2010-02-25 Introduction
2010-April-Guidelines for use of serum free light chain assays	2010-Mar-Cerebrospinal fluid and free light chains	2010-Sep-AL Amyloidosis
2010-Sep-Abbreviations	2010-Sep-Asymptomatic (smouldering) multiple myeloma (ASMM)	2010-Sep-Biology of immunoglobulin light chains
2010-Sep-Cerebrospinal fluid and free light chains	2010-Sep-Classification of diseases with increased immunoglobulins	2010-Sep-Contents
2010-Sep-Dedication and Acknowledgements	2010-Sep-Dr Bence Jones and the history of free light chains	2010-Sep-Immune stimulation and elevated polyclonal free light chains
2010-Sep-Immunoassays for free light chain measurement	2010-Sep-Implementation and interpretation of free light chain assays	2010-Sep-Instrumentation for free light chain immunoassays
2010-Sep-Intact immunoglobulin MM (IIMM) - sFLCs at diagnosis	2010-Sep-Intact immunoglobulin multiple myeloma (IIMM) - theoretical considerations of sFLC and Ig measurements	2010-Sep-Introduction
2010-Sep-Light chain deposition disease (LCDD)	2010-Sep-Light chain multiple myeloma (LCMM)	2010-Sep-Localised amyloid disease
2010-Sep-Monitoring IIMM patients using sFLCs	2010-Sep-Monoclonal gammopathies of undetermined significance (MGUS)	2010-Sep-Multiple myeloma - Introduction
2010-Sep-Nonsecretory multiple myeloma (NSMM)	2010-Sep-Other malignancies with monoclonal FLCs	2010-Sep-Overview - The clinical importance of serum free light chain analysis
2010-Sep-Preface to 1st edition 2003	2010-Sep-Preface to 5th edition	2010-Sep-Quality assurance for serum free light chain analysis
2010-Sep-Questions and answers about FLCs	2010-Sep-Renal diseases and free light chains	2010-Sep-Screening studies using serum free light chain analysis
2010-Sep-Sensitivity of serum free light chain assays	2010-Sep-Serum free light chain publications	2010-Sep-Serum versus urine tests for free light chains
2010-Sep-The kidney and monoclonal free light chains	2011-April-Guidelines for use of serum free light chain assays	2011-Feb-Guidelines for use of serum free light chain assays
2011-March-Asymptomatic (smouldering) multiple myeloma (ASMM)	2011-March-Light chain deposition disease (LCDD)	2011-March-Multiple myeloma - Introduction
7 Introduction	AL Amyloidosis	APR-2012Cerebrospinal fluid and free light chains
APR-2012Contents	APR-2012 Instrumentation for free light chain immunoassays	APR 2012 Hevylite publications
Abbreviations	Analysis of Ig heavy chain/light chain pairs (Hevylite™)	Apr-2012Nonsecretory multiple myeloma (NSMM)
Apr2012Contents	April-Main Page	Asymptomatic (smouldering) multiple myeloma (ASMM)
Biology of immunoglobulin light chains	Cerebrospinal fluid and free light chains	Classification of diseases with increased immunoglobulins
Clinical sensitivity of assays for free light chains	Contents	Data:left
Data:right	Dec-2011-AL Amyloidosis	Dedication and Acknowledgements
Dr Bence Jones and the history of free light chains	Draft-Guidelines for use of serum free light chain assays	FREELITE
Feb-2012AL Amyloidosis	Free light chains and monoclonal gammopathies	Guidelines for use of serum free light chain assays
HEVYLITE	Hevylite publications	Immune stimulation and elevated polyclonal free light chains
Immunoassays for free light chain measurement	Implementation and interpretation of free light chain assays	Important notice
Instrumentation for free light chain immunoassays	Intact immunoglobulin MM (IIMM) - sFLCs at diagnosis	Intact immunoglobulin multiple myeloma (IIMM) - theoretical considerations of sFLC and Ig measurements
Intact immunoglobulin multiple myeloma (IIMM) theoretical considerations of sFLC and Ig measurements	Introduction	Light chain deposition disease (LCDD)
Light chain multiple myeloma (LCMM)	Localised amyloid disease	MAR 2012Questions and answers about FLCs
Main Page	Mar2012AL Amyloidosis	Mar2012 Serum free light chain publications
Mar 2011 Serum versus urine tests for free light chains	May2011Main Page	Monitoring IIMM patients using sFLCs
Monoclonal gammopathies of undetermined significance (MGUS)	Multiple myeloma - Introduction	New Things
Nonsecretory multiple myeloma (NSMM)	Normal ranges and reference intervals	Oct-2011-Normal ranges and reference intervals
Other malignancies with monoclonal FLCs	Overview - The clinical importance of serum free light chain analysis	Preface and Abbreviations
Preface to 1st edition 2003	Preface to 1st editon 2003	Preface to 5th Editon
Preface to 5th edition	Preface to 6th edition	Preface to Epub Editon
Printed boxybar	Quality assurance for serum free light chain analysis	Questions and answers about FLCs
Questions and answers about free light chains	Renal diseases and free light chains	SECTION 10 - Practical aspects
SECTION 11 - Questions and answers	SECTION 12 - Publications	SECTION 13 - Introduction
SECTION 14 – Hevylite publications	SECTION 1 - Immunoglobulin free light chains and their analysis	SECTION 1 - Introduction
SECTION 2 - Free light chains and monoclonal gammopathies	SECTION 2 - Multiple Myeloma	SECTION 3 - AL amyloidosis and light chain deposition disease
SECTION 3 - Diseases with increased polyclonal free light chains	SECTION 4 - General applications of free light chain assays	SECTION 4 - Lymphoma, leukaemia and plasmacytoma
SECTION 4 - Plasmacytoma, lymphoma and leukaemia	SECTION 5 - Monoclonal gammopathy of undetermined significance	SECTION 5 - Practical aspects of serum free light chain testing
SECTION 6 - Appendices	SECTION 6 - Renal Impairment	SECTION 6 - Renal impairment
SECTION 7 - Analysis of Ig heavy chain/light chain pairs (Hevylite™)	SECTION 7 - Inflammatory and infectious diseases	SECTION 8 - Screening for monoclonal gammopathies and urine replacement
SECTION 9 - Guidelines	Screening studies using serum free light chain analysis	Section 1
Section 10	Section 11	Section 12
Section 13	Section 14	Section 1a
Section 2	Section 2a	Section 3
Section 3a	Section 4	Section 4a
Section 5	Section 5a	Section 6
Section 6a	Section 7	Section 7a
Section 8	Section 9	Sensitivity of serum free light chain assays
Serum free light chain publications	Serum versus urine tests for free light chains	Stefanhp:Old Things
Stefanhp:tables	TEST STEFAN CH32	Test
Test1	The kidney and monoclonal free light chains

---

Previous page (07-2011Quality assurance for serum free light chain analysis)